ALKS
Alkermes Plc
NASDAQ: ALKS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$33.71
-1.26% today
Updated 2026-04-29
Market cap
$5.62B
P/E ratio
23.57
P/S ratio
3.81x
EPS (TTM)
$1.43
Dividend yield
—
52W range
$25 – $36
Volume
2.4M
Alkermes Plc (ALKS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $563.38M | $730.48M | $656.31M | $519.90M | $515.60M | $452.45M | $1.44B | $1.47B | $1.58B | $1.92B | $1.86B | $1.73B | $1.80B | $1.83B | $1.81B | $1.95B | $2.02B | $1.96B | $2.14B | $2.06B |
| Cash & equivalents | $83.22M | $320.93M | $101.24M | $73.93M | $79.32M | $38.39M | $83.60M | $96.96M | $167.60M | $224.06M | $181.11M | $186.38M | $191.30M | $266.76M | $203.77M | $272.96M | $337.54M | $292.47M | $457.47M | $291.15M |
| Current assets | $434.09M | $581.86M | $413.16M | $293.18M | $407.10M | $346.37M | $339.15M | $408.59M | $570.10M | $1.05B | $1.02B | $912.61M | $966.06M | $983.25M | $961.97M | $1.11B | $1.06B | $1.13B | $1.49B | $1.42B |
| Total liabilities | $371.14M | $345.84M | $351.00M | $100.67M | $102.98M | $60.43M | $581.37M | $517.92M | $512.40M | $524.43M | $541.47M | $516.94M | $594.42M | $653.72M | $719.96M | $882.75M | $911.90M | $920.23M | $933.54M | $590.59M |
| Current liabilities | $69.58M | $39.40M | $42.02M | $57.53M | $91.14M | $48.06M | $89.16M | $85.93M | $100.90M | $130.58M | $236.21M | $211.99M | $291.12M | $339.77M | $391.11M | $438.26M | $471.29M | $497.74M | $520.22M | $465.20M |
| Long-term debt | $279.52M | $156.90M | $160.32M | $50.22M | — | — | $441.36M | $362.26M | $357.54M | $351.22M | $284.21M | $280.67M | $278.44M | $276.46M | $274.30M | $272.12M | $292.80M | $290.27M | $287.73M | — |
| Shareholder equity | $192.24M | $384.65M | $305.31M | $419.23M | $412.62M | $392.02M | $853.85M | $952.37M | $1.07B | $1.40B | $1.31B | $1.21B | $1.20B | $1.17B | $1.09B | $1.07B | $1.11B | $1.04B | $1.20B | $1.46B |
| Retained earnings | $-627.05M | $-438.22M | $-456.57M | $-351.75M | $-365.69M | $-411.23M | $-524.91M | $-499.92M | $-482.30M | $-512.34M | $-739.50M | $-947.94M | $-1.04B | $-1.19B | $-1.38B | $-1.49B | $-1.54B | $-1.70B | $-1.34B | $-976.46M |
| Accounts receivable | $62.38M | $40.26M | $24.59M | $28.23M | $22.97M | $22.97M | $96.38M | $124.62M | $134.20M | $151.55M | $155.49M | $191.10M | $233.59M | $300.45M | $265.47M | $289.54M | $326.56M | $296.90M | $333.18M | $389.52M |
| Inventory | $13.93M | $23.05M | $18.88M | $20.05M | $20.65M | $20.43M | $39.76M | $43.48M | $46.20M | $51.36M | $38.41M | $63.00M | $93.28M | $90.20M | $101.80M | $125.74M | $150.34M | $181.42M | $186.41M | $182.89M |
| Goodwill | — | — | — | — | — | $92.74M | $92.74M | $92.74M | $92.70M | $94.21M | $92.87M | $92.87M | $92.87M | $92.87M | $92.87M | $92.87M | $92.87M | $83.03M | $83.03M | $83.03M |